These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10633805)

  • 1. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug essentials. The cytochrome P450 microenzyme system and targeted therapies: Minimizing drug interactions.
    Wilkes GM
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl Nurse Ed):33, 52-6. PubMed ID: 19856586
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-associated disease: cytochrome P450 interactions.
    Mann HJ
    Crit Care Clin; 2006 Apr; 22(2):329-45, vii. PubMed ID: 16678003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A basic conceptual and practical overview of interactions with highly prescribed drugs.
    Dresser GK; Bailey DG
    Can J Clin Pharmacol; 2002; 9(4):191-8. PubMed ID: 12584577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K; Khattar SK; Saini KS
    Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes.
    Zebothsen I; Kunze T; Clement B
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):37-43. PubMed ID: 16867169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants.
    Bachmann KA; Lewis JD
    Ann Pharmacother; 2005 Jun; 39(6):1064-72. PubMed ID: 15886285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions evaluation: an integrated part of risk assessment of therapeutics.
    Zhang L; Reynolds KS; Zhao P; Huang SM
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):134-45. PubMed ID: 20045016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450: new nomenclature and clinical implications.
    Cupp MJ; Tracy TS
    Am Fam Physician; 1998 Jan; 57(1):107-16. PubMed ID: 9447218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug interactions of cytochrome p450: an evaluation of fluorogenic to conventional substrates.
    Cohen LH; Remley MJ; Raunig D; Vaz AD
    Drug Metab Dispos; 2003 Aug; 31(8):1005-15. PubMed ID: 12867489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
    Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of obesity on the cytochrome P450 enzyme system.
    Kotlyar M; Carson SW
    Int J Clin Pharmacol Ther; 1999 Jan; 37(1):8-19. PubMed ID: 10027478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
    Crivori P; Poggesi I
    Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated assays for human cytochrome P450 activities.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2004 Jun; 32(6):647-60. PubMed ID: 15155557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions: keeping it straight.
    Anastasio GD; Cornell KO; Menscer D
    Am Fam Physician; 1997 Sep; 56(3):883-8, 891-4. PubMed ID: 9301579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug metabolism and drug interactions in the elderly.
    Herrlinger C; Klotz U
    Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):897-918. PubMed ID: 11866484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.